New distribution! Reach relevant USA TODAY Network news sites. Get started ›

New distribution! Reach relevant USA TODAY Network news sites. Get started ›

World Media Directory · RSS · Email Newsletters

There were 1,587 press releases posted in the last 24 hours and 346,557 in the last 365 days.

Press Releases on January 3, 2019

489 Press Releases

Published on January 3, 2019 - 12:55 GMT

Elixinol Welcomes Hemp Industry Advocate Joy Beckerman As Regulatory Officer & Industry Liaison

DENVER , Jan. 03, 2019 (GLOBE NEWSWIRE) -- Elixinol, a wholly owned subsidiary of Elixinol Global (EXL) (ASX: EXL; OTC: ELLXF), announces Joy Beckerman’s appointment to Elixinol’s team starting January 1, 2019. In Beckerman’s role as Regulatory Officer and …

Distribution channels: Consumer Goods ...
Published on January 3, 2019 - 12:45 GMT

GSRX Industries Inc. Sets Date to Announce 4th Quarter and Annual 2018 Financial and Operating Results

DORADO, Puerto Rico, Jan. 03, 2019 (GLOBE NEWSWIRE) -- GSRX Industries Inc. (OTCQB: GSRX) (“GSRX” or, the “Company”) announced today that it will report fourth quarter and annual 2018 financial and operating results on February 28, 2019. About GSRX …

Distribution channels: Conferences & Trade Fairs, Consumer Goods ...
Published on January 3, 2019 - 12:45 GMT

Oculogica Receives FDA Marketing Authorization for EyeBOX®, the First Non-Invasive, Baseline-Free Test for Concussion

NEW YORK, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Oculogica, Inc., a pioneer in algorithm-based neuro-diagnostics, announced that the U.S. Food and Drug Administration (FDA) granted their De Novo request for the commercialization of EyeBOX®, the first non- …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
Published on January 3, 2019 - 12:45 GMT

Ondas Holdings Inc. Announces Private Placement Offering

SUNNYVALE, Calif., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Ondas Holdings Inc. (OTCQB: ONDS) announced today that it intends to conduct a private placement offering for up to $25 million of its common stock (the “Offering”). The Company intends to use the net …

Distribution channels: Banking, Finance & Investment Industry, Energy Industry ...
Published on January 3, 2019 - 12:40 GMT

Atara Biotherapeutics Announces Planned Chief Executive Officer Transition

SOUTH SAN FRANCISCO, Calif., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases, …

Distribution channels: Banking, Finance & Investment Industry, Technology ...
Published on January 3, 2019 - 12:36 GMT

China Online Gaming (Mobile, PC Online Client Games, Web) Market 2011-2018 & Forecast to 2024

Dublin, Jan. 03, 2019 (GLOBE NEWSWIRE) -- The "China Online Gaming Market, Number of Users, Category (Mobile, PC Online Client Games, Web), Market based on Age Group, Segments & Companies" report has been added to ResearchAndMarkets.com's …

Distribution channels: Banking, Finance & Investment Industry, Technology ...
Published on January 3, 2019 - 12:30 GMT

Amerigo’s MVC Phase Two Expansion Meets Completion Criteria

Amerigo Resources Ltd. (TSX:ARG) VANCOUVER, BRITISH COLUMBIA, CANADA, January 3, 2019 /⁨EINPresswire.com⁩/ -- January 3, 2019 N.R. 2019-01 Amerigo’s MVC Phase Two Expansion Meets Completion Criteria Vancouver, British Columbia – January 3, …

Distribution channels: Mining Industry ...
Published on January 3, 2019 - 12:30 GMT

Detailed Research: Economic Perspectives on Biohaven Pharmaceutical Holding, Air Transport Services Group, Pattern Energy Group, ...

NEW YORK, Jan. 03, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Biohaven Pharmaceutical Holding …

Distribution channels: Banking, Finance & Investment Industry
Published on January 3, 2019 - 12:30 GMT

Kura Oncology to Present at J.P. Morgan Healthcare Conference

SAN DIEGO, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today announced its participation at the 37th Annual J.P. Morgan …

Distribution channels: Conferences & Trade Fairs, Healthcare & Pharmaceuticals Industry ...
Published on January 3, 2019 - 12:30 GMT

NaturalShrimp, Inc. Receives U.S. Patent for System it Developed to Grow Gourmet-Grade Shrimp in Enclosed, Salt-Water System

DALLAS, TX, Jan. 03, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- NaturalShrimp, Inc. (OTCQB: SHMP) is pleased to announce that NaturalShrimp and F&T Water Solutions, LLC have received U.S. Patent No. 10,163,199 B2 for the Recirculating Aquaculture …

Distribution channels: Law
Published on January 3, 2019 - 12:30 GMT

First Patient Enrolled in Biogen’s Phase 3b Study to Evaluate Extended Interval Dosing (EID) with Natalizumab in Multiple ...

Study will provide the first randomized, controlled efficacy and safety data of every-six-week dosing for natalizumab CAMBRIDGE, Mass., Jan. 03, 2019 (GLOBE NEWSWIRE) -- The first patient has been enrolled in a global Phase 3b study evaluating the efficacy …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...
Published on January 3, 2019 - 12:30 GMT

Pacira Reports Preliminary 2018 Net EXPAREL® Sales of $331 Million

PARSIPPANY, N.J., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) today reported preliminary unaudited EXPAREL® (bupivacaine liposome injectable suspension) net product sales of $94 million for the fourth quarter of 2018 and $ …

Distribution channels: Business & Economy ...
Published on January 3, 2019 - 12:30 GMT

Amerigo’s MVC Phase Two Expansion Meets Completion Criteria

VANCOUVER, British Columbia, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Amerigo Resources Ltd. ("Amerigo" or the "Company") (TSX: ARG) is pleased to announce that Minera Valle Central (“MVC”), the Company’s 100% owned operation located near …

Distribution channels: Mining Industry ...
Published on January 3, 2019 - 12:30 GMT

Moleculin Announces Positive Data for its Pancreatic Cancer Drug Candidate

HOUSTON, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company focused on the development of oncology drug candidates, all of which are based on …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on January 3, 2019 - 12:30 GMT

Fairfax Declares Annual Dividend

TORONTO, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Fairfax Financial Holdings Limited (TSX: FFH and FFH.U) announces that it has declared a dividend of US$10.00 per share on its outstanding multiple voting and subordinate voting shares, payable on January 28, 2019 …

Distribution channels: Banking, Finance & Investment Industry
Published on January 3, 2019 - 12:30 GMT

Gran Colombia Gold Adopts Shareholder Rights Plan

TORONTO, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Gran Colombia Gold Corp. (TSX: GCM; OTCQX: TPRFF) announced today that its Board of Directors has adopted a shareholder rights plan agreement (the “Plan”). The Plan is effective immediately and the Toronto Stock …

Distribution channels: Mining Industry ...
Published on January 3, 2019 - 12:30 GMT

DiaMedica Announces FDA Clearance of IND Application To Study DM199 in Patients with Chronic Kidney Disease

MINNEAPOLIS, Jan. 03, 2019 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (“DiaMedica”) (NASDAQ:DMAC) (TSX-V:DMA) announced today that the U.S. Food and Drug Administration ("FDA") has accepted DiaMedica’s Investigational New Drug application (…

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
Published on January 3, 2019 - 12:30 GMT

Translate Bio Appoints Robert Meyer, MD, to its Board of Directors

LEXINGTON, Mass., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
Published on January 3, 2019 - 12:30 GMT

Translate Bio Advances Programs in Cystic Fibrosis (CF) and Ornithine Transcarbamylase (OTC) Deficiency

-- Received approval to begin multiple-ascending dose in Phase 1/2 clinical trial of MRT5005, an mRNA therapeutic for CF -- -- Submitted IND for Phase 1/2 clinical trial of MRT5201, an mRNA therapeutic for OTC deficiency -- LEXINGTON, Mass., Jan. 03, 2019 …

Distribution channels: Technology ...
Published on January 3, 2019 - 12:30 GMT

Kiniksa Announces Active U.S. Investigational New Drug Application for Mavrilimumab

HAMILTON, Bermuda, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (“Kiniksa”), a biopharmaceutical company with a pipeline of five product candidates across various stages of development, today announced an active …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Previous 14 15 16 17 18 19 20 21 22 23 24 Next

Previous Day 2019 Calendar Next Day